News & Updates
Filter by Specialty:
IV steroids may do more harm than good in older-onset ulcerative colitis
In patients with older-onset ulcerative colitis (UC), treatment with intravenous (IV) steroids appears to be less effective and is associated with higher risks of surgery and adverse events relative to patients with younger-onset disease, a study has found.
IV steroids may do more harm than good in older-onset ulcerative colitis
26 Mar 2022
Moderate intake of dietary isoflavone lowers lung cancer risk in nonsmoking women
A moderate increase in the consumption of foods rich in isoflavone can help reduce the risk of lung cancer in women with no smoking history, suggests a study.
Moderate intake of dietary isoflavone lowers lung cancer risk in nonsmoking women
26 Mar 2022
TYK2 inhibitor for psoriatic arthritis clears phase II trial
In the treatment of patients with psoriatic arthritis, the use of the selective TYK2 inhibitor deucravacitinib appears to be effective and well tolerated, leading to greater improvements in American College of Rheumatology (ACR) domains, enthesitis endpoints, and multiple patient-reported, psoriasis-related outcomes relative to placebo, as shown in the results of a phase II trial.
TYK2 inhibitor for psoriatic arthritis clears phase II trial
26 Mar 2022
Death risk higher among older patients likely to delay, miss medical care due to pandemic
Older patients who are strongly likely to delay or miss medical care due to the coronavirus disease 2019 (COVID-19) pandemic are at greater risk of mortality and worse outcomes, a recent study has found.
Death risk higher among older patients likely to delay, miss medical care due to pandemic
25 Mar 2022
Wearable device eases patients with GERD into left-side sleeping
For patients with gastroesophageal reflux disease (GERD), sleeping on the left side is ideal and alleviates nocturnal reflux symptoms. A wearable device can train these patients to sleep in the ideal position, as shown in a study.
Wearable device eases patients with GERD into left-side sleeping
25 Mar 2022
TNFi use does not induce hypertension in ankylosing spondylitis
Use of tumour necrosis factor inhibitor (TNFi) does not appear to contribute to incident hypertension in individuals with ankylosing spondylitis (AS), reports a study.
